Understanding controlled trials: Why are randomised controlled trials important?

BMJ

Volumn 316, Issue 7126, 1998, Pages 201-

  Sibbald, Bonnie ^a   Roland, Martin ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; MEDICAL ETHICS; RANDOMIZED CONTROLLED TRIAL; REVIEW; STANDARD;

ETHICS, MEDICAL; RANDOMIZED CONTROLLED TRIALS;

EID: 0032539329     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.316.7126.201     Document Type: Article

References (8)

1. Schulz KF, Chalmers I, Haynes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273: 408-12.
2. Smithells RW, Shepherd S, Schorah CJ, Seller MJ, Nevin NC, Harris R, et al. Possible prevention of neural tube defects by periconceptional vitamin supplementation. Lancet 1980; 1: 339-40.
3. MRC Vitamin Study Research Group. Prevention of neural tube defects. Results of the Medical Research Council Vitamin Study. Lancet 1991; 338: 131-7.
4. Lanman JT, Guy LP, Dancis J. Retrolental fibroplasia and oxygen therapy. JAMA 1954; 155: 223-5.
5. Fairhurst K, Dowrick C. Problems with recruitment in a randomised controlled trial of counselling in general practice: causes and implications. J Health Serv Res Policy 1996; 1: 77-80.
6. Brewin CR, Bradley C. Patient preferences and randomised clinical trials. BMJ 1989; 299: 313-5.
7. Russell I. Evaluating new surgical procedures. BMJ 1995; 311: 1243-4.
8. Altman DG. Better reporting of randomised controlled trials: the CONSORT statement. BMJ 1996; 313: 370-1.